Pfizer, Novartis jump into an $84M development round for UK cancer drug stars at Artios
Cancer hasn’t lost its sizzle for biotech investors.
VCs at Pfizer and Novartis have jumped into an $84 million round for Artios, a Cambridge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.